Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients

13 páginas

Autores:
Tipo de recurso:
Fecha de publicación:
2023
Institución:
Universidad de la Sabana
Repositorio:
Repositorio Universidad de la Sabana
Idioma:
eng
OAI Identifier:
oai:intellectum.unisabana.edu.co:10818/59036
Acceso en línea:
https://hdl.handle.net/10818/59036
Palabra clave:
Vancomycin
Bayesian prediction
Population pharmacokinetics
Personalized dosing
Individualized therapy
Critical ill patients
Therapeutic drug management
Shiny application
Rights
License
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
id REPOUSABAN_e637400b56fb31dd8a9021b1a50e7ccf
oai_identifier_str oai:intellectum.unisabana.edu.co:10818/59036
network_acronym_str REPOUSABAN
network_name_str Repositorio Universidad de la Sabana
repository_id_str
spelling Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill PatientsVancomycinBayesian predictionPopulation pharmacokineticsPersonalized dosingIndividualized therapyCritical ill patientsTherapeutic drug managementShiny application13 páginasIn individualized therapy, the Bayesian approach integrated with population pharmacokinetic models (PopPK) for predictions together with therapeutic drug monitoring (TDM) to maintain adequate objectives is useful to maximize the efficacy and minimize the probability of toxicity of vancomycin in critically ill patients. Although there are limitations to implementation, model-informed precision dosing (MIPD) is an approach to integrate these elements, which has the potential to optimize the TDM process and maximize the success of antibacterial therapy. The objective of this work was to present an app for individualized therapy and perform a validation of the implemented vancomycin PopPK models. A pragmatic approach was used for selecting the models of Llopis, Goti and Revilla for developing a Shiny app with R. Through ordinary differential equation (ODE)-based mixed effects models from the mlxR package, the app simulates the concentrations¿ behavior, estimates whether the model was simulated without variability and predicts whether the model was simulated with variability. Moreover, we evaluated the predictive performance with retrospective trough concentration data from patients admitted to the adult critical care unit. Although there were no significant differences in the performance of the estimates, the Llopis model showed better accuracy (mean 80.88%; SD 46.5%); however, it had greater bias (mean ¿34.47%, SD 63.38%) compared to the Revilla et al. (mean 10.61%, SD 66.37%) and Goti et al. (mean of 13.54%, SD 64.93%) models. With respect to the RMSE (root mean square error), the Llopis (mean of 10.69 mg/L, SD 12.23 mg/L) and Revilla models (mean of 10.65 mg/L, SD 12.81 mg/L) were comparable, and the lowest RMSE was found in the Goti model (mean 9.06 mg/L, SD 9 mg/L). Regarding the predictions, this behavior did not change, and the results varied relatively little. Although our results are satisfactory, the predictive performance in recent studies with vancomycin is heterogeneous, and although these three models have proven to be useful for clinical application, further research and adaptation of PopPK models is required, as well as implementation in the clinical practice of MIPD and TDM in real time.Universidad de La Sabana2024-01-12T13:17:10Z2024-01-12T13:17:10Z2023-08-09Tesis/Trabajo de grado - Especializaciónhttp://purl.org/coar/resource_type/c_7a1fTextoinfo:eu-repo/semantics/otherhttp://purl.org/redcol/resource_type/COtherinfo:eu-repo/semantics/acceptedVersionapplication/pdfapplication/pdfhttps://hdl.handle.net/10818/5903610.3390/antibiotics12020301engAttribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/http://purl.org/coar/access_right/c_abf2Mena, ManuelGarcia, Julio CesarBustos, Rosa Helenaoai:intellectum.unisabana.edu.co:10818/590362025-12-11T18:16:46Z
dc.title.none.fl_str_mv Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
title Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
spellingShingle Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
Vancomycin
Bayesian prediction
Population pharmacokinetics
Personalized dosing
Individualized therapy
Critical ill patients
Therapeutic drug management
Shiny application
title_short Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
title_full Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
title_fullStr Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
title_full_unstemmed Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
title_sort Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
dc.subject.none.fl_str_mv Vancomycin
Bayesian prediction
Population pharmacokinetics
Personalized dosing
Individualized therapy
Critical ill patients
Therapeutic drug management
Shiny application
topic Vancomycin
Bayesian prediction
Population pharmacokinetics
Personalized dosing
Individualized therapy
Critical ill patients
Therapeutic drug management
Shiny application
description 13 páginas
publishDate 2023
dc.date.none.fl_str_mv 2023-08-09
2024-01-12T13:17:10Z
2024-01-12T13:17:10Z
dc.type.none.fl_str_mv Tesis/Trabajo de grado - Especialización
http://purl.org/coar/resource_type/c_7a1f
Texto
info:eu-repo/semantics/other
http://purl.org/redcol/resource_type/COther
info:eu-repo/semantics/acceptedVersion
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/10818/59036
10.3390/antibiotics12020301
url https://hdl.handle.net/10818/59036
identifier_str_mv 10.3390/antibiotics12020301
dc.language.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Universidad de La Sabana
publisher.none.fl_str_mv Universidad de La Sabana
institution Universidad de la Sabana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1860892063890931712